Suppr超能文献

白色念珠菌临床分离株中的耐药机制。

Resistance mechanisms in clinical isolates of Candida albicans.

作者信息

White Theodore C, Holleman Scott, Dy Francis, Mirels Laurence F, Stevens David A

机构信息

Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington 98109-1651, USA.

出版信息

Antimicrob Agents Chemother. 2002 Jun;46(6):1704-13. doi: 10.1128/AAC.46.6.1704-1713.2002.

Abstract

Resistance to azole antifungals continues to be a significant problem in the common fungal pathogen Candida albicans. Many of the molecular mechanisms of resistance have been defined with matched sets of susceptible and resistant clinical isolates from the same strain. Mechanisms that have been identified include alterations in the gene encoding the target enzyme ERG11 or overexpression of efflux pump genes including CDR1, CDR2, and MDR1. In the present study, a collection of unmatched clinical isolates of C. albicans was analyzed for the known molecular mechanisms of resistance by standard methods. The collection was assembled so that approximately half of the isolates were resistant to azole drugs. Extensive cross-resistance was observed for fluconazole, clotrimazole, itraconazole, and ketoconazole. Northern blotting analyses indicated that overexpression of CDR1 and CDR2 correlates with resistance, suggesting that the two genes may be coregulated. MDR1 overexpression was observed infrequently in some resistant isolates. Overexpression of FLU1, an efflux pump gene related to MDR1, did not correlate with resistance, nor did overexpression of ERG11. Limited analysis of the ERG11 gene sequence identified several point mutations in resistant isolates; these mutations have been described previously. Two of the most common point mutations in ERG11 associated with resistance, D116E and E266D, were tested by restriction fragment length polymorphism analysis of the isolates from this collection. The results indicated that the two mutations occur frequently in different isolates of C. albicans and are not reliably associated with resistance. These analyses emphasize the diversity of mechanisms that result in a phenotype of azole resistance. They suggest that the resistance mechanisms identified in matched sets of susceptible and resistant isolates are not sufficient to explain resistance in a collection of unmatched clinical isolates and that additional mechanisms have yet to be discovered.

摘要

对唑类抗真菌药物产生耐药性仍然是常见真菌病原体白色念珠菌中的一个重大问题。许多耐药分子机制已通过对来自同一菌株的敏感和耐药临床分离株配对组进行定义。已确定的机制包括编码靶酶ERG11的基因改变或包括CDR1、CDR2和MDR1在内的外排泵基因的过表达。在本研究中,通过标准方法分析了一组未配对的白色念珠菌临床分离株的已知耐药分子机制。该分离株集合的构建使得大约一半的分离株对唑类药物耐药。观察到氟康唑、克霉唑、伊曲康唑和酮康唑存在广泛的交叉耐药性。Northern印迹分析表明,CDR1和CDR2的过表达与耐药性相关,这表明这两个基因可能受到共同调控。在一些耐药分离株中很少观察到MDR1过表达。与MDR1相关的外排泵基因FLU1的过表达与耐药性无关,ERG11的过表达也与耐药性无关。对ERG11基因序列的有限分析在耐药分离株中鉴定出几个点突变;这些突变先前已有描述。通过对该集合中的分离株进行限制性片段长度多态性分析,测试了与耐药性相关的ERG11中两个最常见的点突变D116E和E266D。结果表明,这两个突变在不同的白色念珠菌分离株中频繁出现,且与耐药性并无可靠关联。这些分析强调了导致唑类耐药表型的机制的多样性。它们表明,在敏感和耐药分离株配对组中确定的耐药机制不足以解释未配对临床分离株集合中的耐药性,并且尚未发现其他机制。

相似文献

1
Resistance mechanisms in clinical isolates of Candida albicans.白色念珠菌临床分离株中的耐药机制。
Antimicrob Agents Chemother. 2002 Jun;46(6):1704-13. doi: 10.1128/AAC.46.6.1704-1713.2002.
8
Drug resistance genes and trailing growth in Candida albicans isolates.白色念珠菌分离株中的耐药基因与拖尾生长
J Antimicrob Chemother. 2004 Feb;53(2):217-24. doi: 10.1093/jac/dkh040. Epub 2003 Dec 19.

引用本文的文献

本文引用的文献

3
Transcriptional analyses of antifungal drug resistance in Candida albicans.白色念珠菌抗真菌药物耐药性的转录分析
Antimicrob Agents Chemother. 2000 Sep;44(9):2296-303. doi: 10.1128/AAC.44.9.2296-2303.2000.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验